Liu, Wei
Gao, Shandian
Peng, Decai
Su, Jiaoyan
Sui, Jinshu
Wen, Shenghui
Zhou, Tong
Guo, Huichen
Shao, Junjun
Chang, Huiyun
Funding for this research was provided by:
the National Natural Science Foundation of China (32273038)
Article History
Received: 16 July 2026
Revised: 28 October 2026
Accepted: 1 November 2026
First Online: 9 November 2026
Declarations
Ethics approval: All experiments involving live ASFV were performed in biosafety level 3 (BSL-3) and animal biosafety level 3 (ABSL-3) laboratories at the Lanzhou Veterinary Research Institute (LVRI), Chinese Academy of Agricultural Sciences (CAAS). Animal experiments were conducted in accordance with the Animal Ethics Procedures and Guidelines of the People's Republic of China, and the study was approved by the Animal Administration and Ethics Committee of LVRI, CAAS (Permit No. LVRIAEC-2022-085). This approval covered all animal procedures in the study, including the production of mAbs from mouse ascites and the pig vaccination and challenge experiment. Animals were monitored daily and were humanely euthanized upon reaching predefined humane endpoints (moribundity or inability to stand).
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.